Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Symbol
JSPR on Nasdaq
Shares outstanding
28,013,460
Price per share
$1.66
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
10,636,016
Total reported value
$19,453,153
% of total 13F portfolios
0%
Share change
+664,808
Value change
+$140,834
Number of holders
30
Price from insider filings
$1.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7,578,242 2,668,395 Velan Capital Investment Management LP 19 Sep 2025
T. Rowe Price Investment Management, Inc. 7.1% $4,897,117 2,057,612 T. Rowe Price Investment Management, Inc. 30 Sep 2025
MORGAN STANLEY 7% +140% $3,269,843 +$1,967,361 1,969,785 +151% Morgan Stanley 31 Dec 2025
GOLDMAN SACHS GROUP INC 6.3% $2,929,648 1,764,848 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2025
Soleus Capital Master Fund, L.P. 10% $7,068,607 1,494,420 Soleus Capital Management, L.P. 31 Dec 2024
ACORN BIOVENTURES, L.P. 5.3% -18% $2,660,821 -$537,000 1,486,492 -17% Anders Hove 23 Jan 2026
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% -8% $3,153,131 +$1,332,431 1,324,845 +73% Kingdon Capital Management, L.L.C. 30 Sep 2025
Qiming U.S. Healthcare Fund II, L.P. 3.3% $2,210,934 928,964 Qiming U.S. Healthcare Fund II, L.P. 30 Sep 2025
BlackRock, Inc. 1.5% $1,252,311 225,605 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 30 institutional investors reported holding 10,636,016 shares of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR). This represents 38% of the company’s total 28,013,460 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Velan Capital Investment Management LP 9.5% 2,668,395 0% 2.8% $4,883,163
MORGAN STANLEY 7% 1,969,785 +149% 0% $3,604,707
GOLDMAN SACHS GROUP INC 6.2% 1,746,492 +6395% 0% $3,196,080
VANGUARD GROUP INC 4.7% 1,326,512 +28% 0% $2,427,518
Carlyle Group Inc. 3.8% 1,066,189 0% 0.01% $1,940,464
Squarepoint Ops LLC 1% 281,926 +1920% 0% $515,925
BlackRock, Inc. 0.84% 236,224 +15% 0% $432,290
RENAISSANCE TECHNOLOGIES LLC 0.81% 227,183 +9% 0% $415,745
GEODE CAPITAL MANAGEMENT, LLC 0.76% 211,857 +62% 0% $387,788
Soleus Capital Management, L.P. 0.71% 200,000 -87% 0.02% $366,000
Knott David M Jr 0.65% 181,389 +5.8% 0.15% $331,942
UBS Group AG 0.45% 126,361 +221% 0% $231,240
Quarry LP 0.36% 99,529 0.04% $182,138
GSA CAPITAL PARTNERS LLP 0.27% 74,964 0.01% $137,000
JACOBS LEVY EQUITY MANAGEMENT, INC 0.2% 54,800 0% $100,284
IEQ CAPITAL, LLC 0.18% 50,428 +4.8% 0% $92,283
STATE STREET CORP 0.16% 44,699 0% 0% $81,799
PANAGORA ASSET MANAGEMENT INC 0.07% 19,362 0% $35,432
DIMENSIONAL FUND ADVISORS LP 0.07% 18,664 -52% 0% $34,155
Sequent Planning LLC 0.04% 12,500 0% 0.01% $22,875
JANE STREET GROUP, LLC 0.04% 10,364 0% $18,966
FEDERATED HERMES, INC. 0.02% 4,947 +77% 0% $9,053
WELLS FARGO & COMPANY/MN 0% 1,300 -43% 0% $2,379
GROUP ONE TRADING LLC 0% 788 -96% 0% $1,442
CITIGROUP INC 0% 642 0% $1,175

Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,636,016 $19,453,153 +$140,834 $1.83 30
2025 Q3 20,155,363 $47,814,871 +$13,375,645 $2.38 60
2025 Q2 12,514,434 $69,456,410 -$2,535,024 $5.55 63
2025 Q1 13,034,173 $56,047,183 -$70,633,595 $4.30 66
2024 Q4 15,646,434 $334,368,683 +$15,008,656 $21.38 84
2024 Q3 14,676,954 $274,620,688 -$5,485,865 $18.81 77
2024 Q2 14,557,013 $329,580,756 +$34,893,415 $22.70 67
2024 Q1 12,950,959 $379,146,145 +$364,621,578 $29.36 56
2023 Q4 494,706 $390,323 +$390,323 $0.79 1